Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis

Clinica Chimica Acta

Volumn 411, Issue 7-8, 2010, Pages 563-567

  Kumar, Alok ^a   Bala, Lakshmi ^a   Kalita, Jayantee ^a   Misra, U K ^a   Singh, R L ^b   Khetrapal, C L ^a   Babu, G Nagesh ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b DR RAM MANOHAR LOHIA AVADH UNIVERSITY   (India)

Author keywords

Biomarkers; Histidine; Ketones; Motor neuron disease; N acetyl derivatives; Serum metabolites

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETIC ACID; ACETONE; ALANINE; CITRIC ACID; CREATININE; FORMIC ACID; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; HISTIDINE; LYSINE; PYRUVIC ACID; RILUZOLE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; HIRAYAMA DISEASE; HUMAN; MALE; METABOLOMICS; MUSCLE ATROPHY; NECK INJURY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPEECH DISORDER;

3-HYDROXYBUTYRIC ACID; ACETATES; ACETONE; ADULT; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; FORMATES; GLUTAMIC ACID; GLUTAMINE; HISTIDINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS; SENSITIVITY AND SPECIFICITY;

EID: 77649190353     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.01.016     Document Type: Article

References (40)

1. Beghi E., Logroscino G., Chio A., et al. The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta 2006, 1762:1150-1157.
2. Turner M.R., Kiernan M.C., Leigh P.N., Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 2009, 8:94-109.
3. Liscic R.M., Grinberg L.T., Zidar J., Gitcho M.A., Cairns N.J. ALS and FTLD: two faces of TDP-43 proteinopathy. Eur J Neurol 2008, 15:772-780.
4. De Vos K.J., Grierson A.J., Ackerley S., Miller C.C. Role of axonal transport in neurodegenerative diseases. Ann Rev Neurosci 2008, 31:151-173.
5. Shaw P.J. Molecular and cellular pathways of neurodegeneration in motor neurone disease. J Neurol Neurosurg Psychiatry 2005, 76:1046-1057.
6. Schymick J.C., Scholz S.W., Fung H.C., et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 2007, 6:322-328.
7. Schymick J.C., Talbot K., Traynor B.J. Genetics of sporadic amyotrophic lateral sclerosis. Hum Mol Genet 2007, 16:233-242.
8. Hirayama K., Tokumaru Y. Cervical dural sac and spinal cord in juvenile muscular atrophy of distal upper extremity. Neurology 2000, 54:1922-1926.
9. Biondi A., Dormont D., Weitzner I.J., Bouche P., Chaine P., Bories J. MR imaging of the cervical cord in juvenile amyotrophy of distal upper extremity. Am J Neuroradiol 1989, 10:263-268.
10. Kohno M., Takahashi H., Yagishita A., Tanabe H. Disproportion theory of the cervical spine and spinal cord in patients with juvenile cervical flexion myelopathy: a study comparing cervical magnetic resonance images with those of normal controls. Surg Neurol 1998, 50:421-430.
11. Pradhan S, Gupta RK. Magnetic resonance imaging in juvenile asymmetric segmental spinal muscular atrophy. J Neurol Sci 1997; 146:133-138.
12. Misra U.K., Kalita J., Mishra V.N., Kesari A., Mittal B. A clinical, magnetic resonance imaging, and survival motor neuron gene deletion study of Hirayama disease. Arch Neurol 2005, 62:120-123.
13. Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1:293-299.
14. Hirayama K. Nonprogressive juvenile spinal muscular atrophy of the distal upper limb (Hirayama's disease). Handbook of clinical neurology 1991, vol. 15:107-120. Elsevier, Amsterdam. J.M.B.V. De Jong (Ed.).
15. Meiboom S., Gill D. Modified spin echo method for measuring nuclear relaxation times. Rev Sci Instrum 1958, 29:688-691.
16. Bell J.D., Brown J.C., Nicholson J.K., Sadler P.J. Assignment of resonances for 'acute-phase' glycoproteins in high resolution proton NMR spectra of human blood plasma. FEBS Lett 1987, 215:311-315.
17. Engelke U.F.H., Liebrand-van Sambeek M.L.F., Jong J.G.N., et al. N-acetylated metabolites in urine: proton nuclear magnetic resonance spectroscopic study on patients with inborn errors of metabolism. Clin Chem 2004, 50:58-66.
18. Lindon J.C., Nicholson J.K., Everett J.R. NMR spectroscopy of biofluids. Ann Rep NMR Spectrosc 1999, 38:1-88.
19. Derome A., Williamson M. 2D homonuclear shift correlation phase sensitive using TPPI with double quantum filter phase cycle. J Magn Reson 1990, 88:177-185.
20. Bax A., Davis D.G. MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy. J Magn Reson 1985, 65:355-360.
21. Bala L., Sharma A., Yellappa R.K., Roy R., Choudhuri G., Khetrapal C.L. (1)H NMR spectroscopy of ascitic fluid: discrimination between malignant and benign ascites and comparison of the results with conventional methods. NMR Biomed 2008, 21:606-614.
22. Trotti D., Aoki M., Pasinelli P., et al. Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity. J Biol Chem 2001, 276:576-582.
23. Babu G.N., Bawari M., Mathur V.N., Kalita J., Misra U.K. Blood glutamate concentrations in patients with motor neuron disease. Clin Chim Acta 1998, 273:195-200.
24. Plaitakis A. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis. Ann Neurol 1990, 28:3-8.
25. Pioro E.P. MR spectroscopy in amyotrophic lateral sclerosis/motor neuron disease. J Neurol Sci 1997, 152:49-53.
26. Nicholls P. Formate as an inhibitor of cytochrome c oxidase. Biochem Biophys Res Commun 1975, 67:610-616.
27. Wade A.M., Tucker H.N. Antioxidant characteristics of l-histidine. J Nutr Biochem 1998, 9:308-315.
28. Tang S.C., Arumugam T.V., Cutler R.G., et al. Neuroprotective actions of a histidine analogue in models of ischemic stroke. J Neurochem 2007, 101:729-736.
29. Irisawa Y., Adachi N., Liu K., Arai T., Nagaro T. Alleviation of ischemia-induced brain edema by activation of the central histaminergic system in rats. J Pharmacol Sci 2008, 108:112-123.
30. Watanabe M., Suliman M.E., Qureshi A.R., et al. Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality. Am J Clin Nutr 2008, 87:1860-1866.
31. Kashiwaya Y., Takeshima T., Mori N., Nakashima K., Clarke K., Veech R.L. d-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA 2000, 97:5440-5444.
32. Sato K., Kashiwaya Y., Keon C.A., et al. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J 1995, 9:651-658.
33. Kashiwaya Y., King M.T., Veech R.L. Substrate signaling by insulin: a ketone bodies ratio mimics insulin action in heart. Am J Cardiol 1997, 80:50A-64A.
34. Babu G.N., Kumar A., Chandra R., et al. Oxidant-antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease. Neurochem Int 2008, 52:1284-1289.
35. Tavazzi B., Signoretti S., Lazzarino G., et al. Cerebral oxidative stress and depression of energy metabolism correlate with severity of diffuse brain injury in rats. Neurosurgery 2005, 56:582-589. discussion 582-589.
36. Vagnozzi R., Signoretti S., Tavazzi B., et al. Hypothesis of the postconcussive vulnerable brain: experimental evidence of its metabolic occurrence. Neurosurgery 2005, 57:164-171. discussion 164-171.
37. Pyra T., Hui B., Hanstock C., et al. Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009, 16:1-9.
38. Bradley W.G., Bowen B.C., Pattany P.M., Rotta F. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J Neurol Sci 1999, 169:84-86.
39. Shaw P.J., Forrest V., Ince P.G., Richardson J.P., Wastell H.J. CSF and plasma amino acid concentrations in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 1995, 4:209-216.
40. Heath P.R., Shaw P.J. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve 2002, 26:438-458.